Anti-cancer

Ruxolitinib

Also known as: Ruxolitinib Phosphate

CAS No. 941678-49-5

A JAK1/JAK2 inhibitor used in oral formulations for myelofibrosis, polycythemia vera, and graft-versus-host disease.

Ruxolitinib is a targeted JAK-inhibitor oncology/hematology API manufactured by NovaAcura Biotech under strict GMP quality systems. Full batch documentation and regulatory support are available for global formulation partners.

Applications & Uses

A JAK1/JAK2 inhibitor used in oral formulations for myelofibrosis, polycythemia vera, and graft-versus-host disease.

Full technical documentation, batch specifications and regulatory support (DMF/CEP) are available on request.

Need This Molecule at Scale?

Get in touch for pricing, lead times and full regulatory documentation.

Get In Touch